• KolmarBNH will absorb its wholly owned cosmetics and pharmaceuticals subsidiary HNG, with the merger scheduled for Dec. 29, 2026.
• The transaction aims to consolidate operations, reduce duplicate costs and improve resource management.
• No new shares will be issued, leaving share capital and the controlling shareholder unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KolmarBNH Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261028000374), on October 28, 2026, and is solely responsible for the information contained therein.